Faster global financial news!
Antibody-drug conjugate
-
Samsung Bioepis' first ADC candidate SBE303 wins FDA Fast Track designation for urothelial cancer treatment
Samsung Bioepis announced Wednesday that its first antibody-drug conjugate (ADC) candidate, SBE303, has been granted Fast Track designation by the US Food and Drug Administration (FDA). SBE303 targets
-
Samsung Bioepis' first ADC candidate SBE303 wins FDA Fast Track designation for urothelial cancer treatment
Samsung Bioepis announced Wednesday that its first antibody-drug conjugate (ADC) candidate, SBE303, has been granted Fast Track designation by the US Food and Drug Administration (FDA). SBE303 targets
- No data
Antibody-drug conjugate
24H Trending
-
1
HSBC CEO warns not all data centers are good bets amid AI boom
-
2
Chinese Carmakers Accelerate European Production Plans to Bypass EU Tariffs and Import Quotas on EVs
-
3
Private credit firm Tikehau is reportedly seeking strategic investors to fuel growth.
-
4
Denmark's financial regulator stated that the country's economic growth is expected to slow as the pharmaceutical boom led by Novo Nordisk loses momentum.
-
5
U.S. Secretary of State Rubio visited India's Reliance refinery to discuss increasing the refining of Venezuelan crude oil, aiming to balance sanctions against Russia with oil price stability.
-
6
Montage Technology expects Q3 net profit to increase by 153.6%~174.7% year-on-year, reaching 1.2 billion to 1.3 billion yuan.
-
7
CATL and Huawei Qiankun signed an intelligent energy replenishment agreement to jointly explore unmanned energy replenishment scenarios.
-
8
Wallstreetcn: Hedge Fund Leverage Hits Five-Year Low, Tech Stocks See Largest Net Sell-Off in History
-
9
Rubio Says Trump 'Frustrated' at Accusations He Harming Ukraine
-
10
Bloomberg Strategist Simon White: The signal for a peak in US equities is not in the bond market, but in Asian chip export data.
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
